New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
What Comes after NCI-MATCH? NCI’s New Precision Medicine Cancer Trials

What Comes after NCI-MATCH? NCI’s New Precision Medicine Cancer Trials

SubscribeDecember 6, 2023, by James H. Doroshow, M.D.Findings from NCI-MATCH and its successor trials will help oncologists implement precision medicine in everyday patient care.Credit: iStockMore tha
Oncology December 19,2023
What Comes after NCI-MATCH? NCI’s New Precision Medicine Cancer Trials

What Comes after NCI-MATCH? NCI’s New Precision Medicine Cancer Trials

SubscribeDecember 6, 2023, by James H. Doroshow, M.D.Findings from NCI-MATCH and its successor trials will help oncologists implement precision medicine in everyday patient care.Credit: iStockMore tha
Oncology December 19,2023
“The power of science”: HPV vaccine proven to dramatically reduce cervical cancer

“The power of science”: HPV vaccine proven to dramatically reduce cervical cancer

byLilly Matson| Analysis3 November 2021Share this articleAlmost all cervical cancers are caused by the human papilloma virus (HPV), depicted above.After decades of research,the UK im
Oncology December 19,2023
“The power of science”: HPV vaccine proven to dramatically reduce cervical cancer

“The power of science”: HPV vaccine proven to dramatically reduce cervical cancer

byLilly Matson| Analysis3 November 2021Share this articleAlmost all cervical cancers are caused by the human papilloma virus (HPV), depicted above.After decades of research,the UK im
Oncology December 19,2023
Targeting epiregulin in treatment-damaged tumor microenvironment restrains therapeutic resistance

Targeting epiregulin in treatment-damaged tumor microenvironment restrains therapeutic resistance

by Liu Jia,Chinese Academy of SciencesGenotoxicity induces expression of EREG and other secreted factors of the SASP spectrum in human stromal cells.aTranscriptome-wide profiling of
Oncology December 19,2023
Targeting epiregulin in treatment-damaged tumor microenvironment restrains therapeutic resistance

Targeting epiregulin in treatment-damaged tumor microenvironment restrains therapeutic resistance

by Liu Jia,Chinese Academy of SciencesGenotoxicity induces expression of EREG and other secreted factors of the SASP spectrum in human stromal cells.aTranscriptome-wide profiling of
Oncology December 19,2023
Australia on track to be the first country to eliminate cervical cancer, but inequities persist

Australia on track to be the first country to eliminate cervical cancer, but inequities persist

by Dr Tessa Saunders, Dr Claire Nightingale, Associate Professor Megan Smith and Claire Bavor,University of MelbourneSelf-screening for HPV is one way to remove barriers to screening. Credit: Au
Oncology December 19,2023
Australia on track to be the first country to eliminate cervical cancer, but inequities persist

Australia on track to be the first country to eliminate cervical cancer, but inequities persist

by Dr Tessa Saunders, Dr Claire Nightingale, Associate Professor Megan Smith and Claire Bavor,University of MelbourneSelf-screening for HPV is one way to remove barriers to screening. Credit: Au
Oncology December 19,2023
Targeting menin induces responses in acute leukemias with KMT2A rearrangements or NPM1 mutations

Targeting menin induces responses in acute leukemias with KMT2A rearrangements or NPM1 mutations

byUniversity of Texas M. D. Anderson Cancer CenterBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaResearchers from The University of Texas MD
Oncology December 19,2023
Targeting menin induces responses in acute leukemias with KMT2A rearrangements or NPM1 mutations

Targeting menin induces responses in acute leukemias with KMT2A rearrangements or NPM1 mutations

byUniversity of Texas M. D. Anderson Cancer CenterBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaResearchers from The University of Texas MD
Oncology December 19,2023
Putting liquid biopsies on solid ground: Cancer diagnosis from a milliliter of blood

Putting liquid biopsies on solid ground: Cancer diagnosis from a milliliter of blood

byWeizmann Institute of ScienceSingle-molecule DNA sequencing technical setup. Schematic representation of key instrumentation used to perform single-molecule DNA sequencing. Straight and dashed
Oncology December 19,2023
Putting liquid biopsies on solid ground: Cancer diagnosis from a milliliter of blood

Putting liquid biopsies on solid ground: Cancer diagnosis from a milliliter of blood

byWeizmann Institute of ScienceSingle-molecule DNA sequencing technical setup. Schematic representation of key instrumentation used to perform single-molecule DNA sequencing. Straight and dashed
Oncology December 19,2023
Australian scientists closer to finding new lung cancer treatments

Australian scientists closer to finding new lung cancer treatments

byAustralian National UniversityAssociate Professor Marian Burr. Credit: Jamie Kidston/ANUScientists from The Australian National University (ANU) and the Peter MacCallum Cancer Centre have disc
Oncology December 19,2023
Australian scientists closer to finding new lung cancer treatments

Australian scientists closer to finding new lung cancer treatments

byAustralian National UniversityAssociate Professor Marian Burr. Credit: Jamie Kidston/ANUScientists from The Australian National University (ANU) and the Peter MacCallum Cancer Centre have disc
Oncology December 19,2023
Could a dramatic rise in liver cancer in Australia be linked to climate change?

Could a dramatic rise in liver cancer in Australia be linked to climate change?

byQueensland University of TechnologyCredit:Science of The Total Environment(2022). DOI: 10.1016/j.scitotenv.2022.160412Professor Wenbiao Hu from the QUT School of Public Health and
Oncology December 19,2023
Could a dramatic rise in liver cancer in Australia be linked to climate change?

Could a dramatic rise in liver cancer in Australia be linked to climate change?

byQueensland University of TechnologyCredit:Science of The Total Environment(2022). DOI: 10.1016/j.scitotenv.2022.160412Professor Wenbiao Hu from the QUT School of Public Health and
Oncology December 19,2023
Australian research shows rates of obesity-related cancers quadrupled in a generation

Australian research shows rates of obesity-related cancers quadrupled in a generation

by Cancer CouncilCredit: CC0 Public DomainNew research by the Daffodil Center, a joint venture of Cancer Council NSW and the University of Sydney, shows the rate of obesity-related cancers in Australi
Oncology December 19,2023
Australian research shows rates of obesity-related cancers quadrupled in a generation

Australian research shows rates of obesity-related cancers quadrupled in a generation

by Cancer CouncilCredit: CC0 Public DomainNew research by the Daffodil Center, a joint venture of Cancer Council NSW and the University of Sydney, shows the rate of obesity-related cancers in Australi
Oncology December 19,2023
Olaparib and adavosertib work best when given sequentially for DNA-damage response mutations in advanced tumors

Olaparib and adavosertib work best when given sequentially for DNA-damage response mutations in advanced tumors

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainPatients with cancers that are driven by certain mutations occurring in response to DNA damage can be safe
Oncology December 19,2023
Olaparib and adavosertib work best when given sequentially for DNA-damage response mutations in advanced tumors

Olaparib and adavosertib work best when given sequentially for DNA-damage response mutations in advanced tumors

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainPatients with cancers that are driven by certain mutations occurring in response to DNA damage can be safe
Oncology December 19,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com